Govardhan C P, Abeles R H
Vertex Pharmaceuticals, Inc., Cambridge, Massachusetts, 02254, USA.
Arch Biochem Biophys. 1996 Jun 1;330(1):110-4. doi: 10.1006/abbi.1996.0231.
The cysteine proteases papain and cathepsin B are inactivated by a Michael acceptor, a peptidyl-beta-chloro-alpha, beta-unsaturated ester (N-Ac-L-Phe-NHCH2-CCl=CH-COOMe). Inactivation occurred concomitant with chloride release which was stoichiometric with the amount of enzyme. This result is consistent with nucleophilic attack of the active site cysteine on the beta-carbon of the inhibitor, followed by expulsion of chloride ion. Inactivation by this class of compounds requires the carbon skeleton about the double bond to be in the trans configuration. The cis isomer was a competitive inhibitor. The difference in the mode of inhibition between the isomers is probably due to non-productive binding of the cis isomer due to bulky chlorine substituent in the beta-position.
半胱氨酸蛋白酶木瓜蛋白酶和组织蛋白酶B可被迈克尔受体(一种肽基-β-氯-α,β-不饱和酯,即N-乙酰-L-苯丙氨酰-NHCH2-CCl=CH-COOMe)灭活。灭活过程伴随着氯离子的释放,释放的氯离子与酶的量呈化学计量关系。这一结果与活性位点半胱氨酸对抑制剂β-碳的亲核攻击,随后氯离子的排出相一致。这类化合物的灭活要求双键周围的碳骨架为反式构型。顺式异构体是一种竞争性抑制剂。异构体之间抑制模式的差异可能是由于β位上庞大的氯取代基导致顺式异构体的非生产性结合。